Short Intervention for Medication Overuse Headache (MOH) - Pilot (SIMOHpilot)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is together with the BIMOH (NCT01314768) RCT study to evaluate whether training of GPs in the detection and treatment of medication overuse headache leads to improved care for these patients as compared to "business as usual".
| Condition | Intervention |
|---|---|
|
Medication Overuse Headache |
Behavioral: Trained counselling |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | Pilot Study of Short Intervention for Medication Overuse Headache in General Practice |
- Qualitative comments of participants on acceptability and utility [ Time Frame: 2 months ] [ Designated as safety issue: No ]
- Qualitative comments of participants on acceptability and utility. [ Time Frame: 2 months ] [ Designated as safety issue: No ]
- Number of medication days per month [ Time Frame: 2 months ] [ Designated as safety issue: No ]
| Enrollment: | 5 |
| Study Start Date: | March 2010 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Trained counselling
Comparison of outcomes before intervention vs. 2 months after
|
Behavioral: Trained counselling |
Detailed Description:
The present pilot study focuses on testing the logistics and the methodology of short intervention on a pilot group of GPs and their patients.
Due to low recruitment and the pilot study focus on logistics and methodology, the study was changed to not include a control (business as usual) arm. The outcomes were evaluated as "before - after" data and qualitative comments on acceptability and utility of the method. Primary outcomes were changed to be the acceptability and utility (previously listed as secondary outcomes) while secondary outcomes were headache days and medication days (previously listed as primary).
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosed with medication overuse headache
Exclusion Criteria:
- Other complicating pain condition
Contacts and Locations| Norway | |
| Department of General Practice and Community Medicine | |
| Oslo, Norway, 0318 | |
More Information
No publications provided
| Responsible Party: | Christofer Lundqvist, Principal Investigator, Akershus University College |
| ClinicalTrials.gov Identifier: | NCT01078012 History of Changes |
| Other Study ID Numbers: | SIMOH pilot |
| Study First Received: | March 1, 2010 |
| Last Updated: | January 9, 2013 |
| Health Authority: | Norway: Norwegian Directory of Health Norway: Data Protection Authority |
Additional relevant MeSH terms:
|
Headache Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 21, 2013